BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17244343)

  • 1. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
    Kerr AC; Ferguson J; Ibbotson SH
    Clin Exp Dermatol; 2007 Mar; 32(2):201-2. PubMed ID: 17244343
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
    Yokoyama S; Nakano H; Nishizawa A; Kaneko T; Harada K; Hanada K
    J Dermatol; 2005 Oct; 32(10):843-7. PubMed ID: 16361740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate whealing urticaria in red light exposed areas during photodynamic therapy.
    Kaae J; Philipsen PA; Haedersdal M; Wulf HC
    Acta Derm Venereol; 2008; 88(5):480-3. PubMed ID: 18779886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy.
    Clark C; Dawe RS; Moseley H; Ferguson J; Ibbotson SH
    Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):105-7. PubMed ID: 15030596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.
    Maydan E; Nootheti PK; Goldman MP
    J Drugs Dermatol; 2006 Sep; 5(8):804-6. PubMed ID: 16989196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urticaria-like reaction secondary to photodynamic therapy in 2 pediatric patients.
    Miguélez A; Martín-Santiago A; Bauzá A; Gilaberte Y
    Actas Dermosifiliogr; 2013 Oct; 104(8):727-9. PubMed ID: 23954045
    [No Abstract]   [Full Text] [Related]  

  • 7. Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy.
    Guarneri C; Vaccaro M
    J Am Acad Dermatol; 2009 Mar; 60(3):521-2. PubMed ID: 19231656
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy.
    Sylantiev C; Schoenfeld N; Mamet R; Groozman GB; Drory VE
    Muscle Nerve; 2005 Mar; 31(3):390-3. PubMed ID: 15490483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
    Wolfe CM; Green WH; Hatfield HK; Cognetta AB
    J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late erythema after photodynamic therapy to the face.
    Misra A; Maybury K; Eltigani TA
    Plast Reconstr Surg; 2006 Jun; 117(7):2522-3. PubMed ID: 16772986
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical photodynamic therapy for dermatologic disorders: results and complications.
    Redbord KP; Hanke CW
    J Drugs Dermatol; 2007 Dec; 6(12):1197-202. PubMed ID: 18189059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photosensitization induced by exposure to colour cathode ray tube monitor following topical 5-aminolaevulinic acid-based photodynamic therapy: a case report.
    Wang X; Wang H; Huang Z
    Acta Derm Venereol; 2010 Sep; 90(5):545-7. PubMed ID: 20814646
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.
    Gold MH; Biron J
    J Drugs Dermatol; 2006 Sep; 5(8):796-8. PubMed ID: 16989195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of squamous cell carcinoma after photodynamic therapy with methyl aminoleuvulinate.
    Calista D
    Br J Dermatol; 2014 Oct; 171(4):905-8. PubMed ID: 24702060
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site.
    Wolf P; Fink-Puches R; Reimann-Weber A; Kerl H
    Dermatology; 1997; 194(1):53-4. PubMed ID: 9031792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy update 2007.
    Gold MH
    J Drugs Dermatol; 2007 Nov; 6(11):1131-7. PubMed ID: 18038501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy.
    Oseroff AR; Shieh S; Frawley NP; Cheney R; Blumenson LE; Pivnick EK; Bellnier DA
    Arch Dermatol; 2005 Jan; 141(1):60-7. PubMed ID: 15655143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides showing incomplete response to topical 5-aminolaevulinic acid phototherapy.
    Kim EH; Kang HY; Lee ES; Kim YC
    Eur J Dermatol; 2007; 17(4):343-5. PubMed ID: 17540651
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminolevulinic acid-photodynamic therapy for photorejuvenation.
    Nootheti PK; Goldman MP
    Dermatol Clin; 2007 Jan; 25(1):35-45. PubMed ID: 17126740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.